OVID | Ovid Therapeutics Inc
Category: Consumer goods
Quick infos Headquarters: United States of America Trade prices Volume: Market Cap: 267.62M Prev closed: 4.02 Open: 4.03 High: 4.14 Low: 3.97 52 week low: 2.25 52 week high: 9.4 Dividends: No Dividends Next ER: May 6, 2021
Earnings History Date EPS / Forecast Revenue / Forecast May 11, 2021 April 1, 2021 - / -0.3099- / 4.16MNovember 12, 2020 -0.28 / -0.35046.91M / 100KAugust 10, 2020 -0.41 / -0.36- / -May 7, 2020 -0.37 / -0.33- / -view more
Historical Data Date Price Open High Low Vol Change ER Apr 1, 2021 4.07 4.03 4.14
3.97
981.41K 1.24% Mar 31, 2021 4.02 3.81 4.08
3.81
860.11K 4.42% Mar 30, 2021 3.85 4.01 4.02
3.77
928.86K 1.58% Mar 29, 2021 3.79 3.92 3.96
3.79
1.01M -4.53% Mar 26, 2021 3.97 4.08 4.08
3.88
898.31K -2.7% Mar 25, 2021 4.08 3.79 4.09
3.78
899.08K 5.70% Mar 24, 2021 3.86 4.06 4.09
3.84
1.30M -2.77% Mar 23, 2021 3.97 4.20 4.31
3.96
1.87M -7.24% Mar 22, 2021 4.28 4.40 4.45
4.27
971.33K -4.25% Mar 19, 2021 4.47 4.30 4.49
4.24
1.76M 5.92% view more
NASDAQ - Nasdaq Stock Market
More profiles and info about the company News
Benzinga's Top Upgrades, Downgrades For December 2, 2020 finance.yahoo.com Apr 2, 2021 9:52 am 5 Top Stock Gainers for Wednesday: Michaels, Alcoa, Ovid Therapeutics thestreet.com Apr 2, 2021 7:40 am
Takeda Secures Global Rights from Ovid Therapeutics to Develop and Commercialize Soticlestat for the Treatment of Children and Adults with Dravet Syndrome and Lennox-Gastaut Syndrome finance.yahoo.com Apr 2, 2021 7:00 am OVID Stock Price Increased Over 5% Pre-Market: Why It Happened pulse2.com Mar 31, 2021 2:57 pm
Ovid Therapeutics Announces Closing of Agreement with Takeda for Global Development and Commercialization of Soticlestat finance.yahoo.com Mar 30, 2021 8:00 am Ovid Therapeutics Inc. (NASDAQ:OVID) Just Reported Full ... simplywall.st Mar 19, 2021 2:57 pm Analysts Just Made A Captivating Upgrade To Their Ovid ... simplywall.st Mar 19, 2021 2:57 pm Ovid Therapeutics EPS misses by $0.04, beats on revenue seekingalpha.com Mar 15, 2021 9:29 pm Ovid downgraded to sector perform at RBC as shares surge 34% on Takeda deal seekingalpha.com Mar 4, 2021 1:29 am Ovid shares surge 92% after soticlestat deal with Takeda seekingalpha.com Mar 3, 2021 8:21 pm OVID Stock News: The Big Deal That Has Ovid Therapeutics ... nasdaq.com Mar 2, 2021 2:57 pm Should You Buy Ovid Therapeutics Inc (OVID) Stock Wednesday Morning? investorsobserver.com Mar 2, 2021 2:57 pm OVID Stock Price Increases Over 60% Pre-Market: Why It Happened pulse2.com Mar 2, 2021 2:57 pm Why Ovid Therapeutics Stock Is Imploding Today fool.com Dec 2, 2020 11:38 am Ovid Posts Larger-Than-Feared Quarterly Loss, Revenue Beat finance.yahoo.com Mar 19, 2021 2:57 pm What Kind Of Investors Own Most Of Ovid Therapeutics Inc. (NASDAQ:OVID)? finance.yahoo.com Mar 12, 2021 2:57 pm
Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index finance.yahoo.com Dec 16, 2020 7:00 am
Ovid Therapeutics to Host Conference Call and Webcast on Thursday, October 25, at 10:30 a.m. EDT finance.yahoo.com Dec 2, 2020 8:00 am
The Daily Biotech Pulse: Teva Settles With FTC, Setback For Merck In Liver Cancer Trial, Sienna Biopharma Offering finance.yahoo.com Dec 2, 2020 7:34 am This company doesn't provide a dividend.
Talk about Ovid Therapeutics Inc below in comments section below. Do you think you'll buy? Do you already have active trades now?
EarningsAhead is not affiliated with and this is not an endorsement of the companies featured above.
Share it with fellow traders:
or join discussions in FB below
(
FB comments )
If you are looking for News & events, Press Release, they are available on their Investors Relations site.
Consensus
If you want to help pay for server cost or for improving this tool. You can send it via Paypal .
Buy on Amazon Technical analysis is a collection of techniques designed to help you make trading decisions in securities markets. Technical Analysis For Dummies helps you take a hard-headed look at what securities prices are actually doing rather than what economists or analysts say they should be doing, giving you the know-how to use that data to decide whether to buy or sell individual securities.
A simple, straightforward guide to the fundamentals of technical analysis
